FORA Capital LLC Acquires 89,493 Shares of Haleon PLC Sponsored ADR $HLN

Key Points

• FORA Capital LLC significantly increased its holdings in Haleon PLC shares by 721.4%, owning a total of 101,898 shares valued at approximately $1,049,000.
• Haleon recently declared a semi-annual dividend of $0.0555, an increase from the previous dividend of $0.05, representing a yield of 190.0%.
• Several firms, including BNP Paribas and Morgan Stanley, have upgraded their ratings for Haleon, with a consensus price target of $12.33 and a consensus rating of "Moderate Buy."

FORA Capital LLC increased its holdings in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 721.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 101,898 shares of the company's stock after buying an additional 89,493 shares during the period. FORA Capital LLC's holdings in Haleon were worth $1,049,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Wellington Management Group LLP boosted its holdings in Haleon by 22.0% in the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company's stock valued at $192,428,000 after purchasing an additional 3,372,155 shares during the period. Nuveen LLC bought a new position in Haleon in the 1st quarter valued at $58,870,000. Northern Trust Corp boosted its holdings in Haleon by 27.7% in the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock valued at $51,636,000 after purchasing an additional 1,172,931 shares during the period. Point72 Asset Management L.P. bought a new position in Haleon in the 4th quarter valued at $45,110,000. Finally, Bain Capital Public Equity Management II LLC boosted its holdings in Haleon by 6.2% in the 4th quarter. Bain Capital Public Equity Management II LLC now owns 2,844,010 shares of the company's stock valued at $27,132,000 after purchasing an additional 165,929 shares during the period. 6.67% of the stock is owned by institutional investors.

Haleon Trading Up 1.2%

Shares of HLN traded up $0.12 during trading hours on Monday, reaching $9.81. 8,278,049 shares of the company traded hands, compared to its average volume of 8,264,119. The company's fifty day moving average price is $9.85 and its two-hundred day moving average price is $10.21. The company has a market capitalization of $43.96 billion, a price-to-earnings ratio of 25.14, a price-to-earnings-growth ratio of 2.89 and a beta of 0.23. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42.

Haleon Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be paid a dividend of $0.0555 per share. The ex-dividend date of this dividend is Friday, August 15th. This is an increase from Haleon's previous semi-annual dividend of $0.05. This represents a yield of 190.0%. Haleon's payout ratio is presently 28.21%.

Wall Street Analyst Weigh In

Several brokerages have commented on HLN. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Wall Street Zen cut shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective on the stock in a research report on Tuesday, May 27th. Barclays restated an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Finally, Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price on the stock in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.